• 1
    Inoue J, Hoshino R, Nojima H, Okamoto N. Investigation of the short-term and long-term effect of donepezil on cognitive function in Alzheimer's disease. Psychogeriatrics 2009; 9: 2733.
  • 2
    Inoue J, Hoshino R, Nojima H, Okamoto N. Effects of donepezil hydrochloride on cognitive function in patients with Alzheimer-type dementia. Jpn J Geriatr Psychiatry 2007; 18: 9931002 (in Japanese).
  • 3
    Mckhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984; 34: 939944.
  • 4
    Folstein MF, Folstein SE, McHugh PR. ‘Mini-Mental State’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189198.
  • 5
    Hoshino R, Miyasato K, Okamoto N, Kondo N, Ohara K, Arima R. A comparative study of cognitive function in patients with senile dementia of Alzheimer-type and vascular dementia. Jpn J Geriatric Psychiatry 1994; 5: 6371 (in Japanese).
  • 6
    Hoshino R, Miyasato K, Okamoto N, Kondo N, Ohara K, Arima R. A study on the new Rorschach scale for evaluating cognitive function in aged person. Jpn J Geriatric Psychiatry 1996; 7: 409421 (in Japanese).
  • 7
    Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566572.
  • 8
    Kumagai R, Matsumlya M, Tada Y, Miyakawa K, Lchimlya Y, Arai H. Long-term effect of donepezil for Alzheimer's disease: Retrospective clinical evaluation of drug efficacy in Japanese patients. Psychogeriatrics 2008; 8: 1923.
  • 9
    Nozawa M, Ichimiya Y, Nozawa E et al. Clinical effect of high oral dose of donepezil for patient with Alzheimer's disease in Japan. Psychogeriatrics 2009; 9: 5055.